BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1107725)

  • 1. Lepromatous leprosy in the nose after one year of dapsone treatment: clinical and bacteriological findings.
    Barton RP; Hogerzeil LM
    Lepr Rev; 1975 Dec; 46(4):257-65. PubMed ID: 1107725
    [No Abstract]   [Full Text] [Related]  

  • 2. Lepromatous leprosy in the nose after one year of dapsone treatment: histopathological findings.
    McDougall AC; Weddell AG; Rees RJ
    Lepr Rev; 1975 Dec; 46(4):267-77. PubMed ID: 1107726
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of nasal lesions in early lepromatous leprosy.
    Barton RP
    Ann R Coll Surg Engl; 1975 Dec; 57(6):309-12. PubMed ID: 1108744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
    Waters MF; Rees RJ; McDougall AC; Weddell AG
    Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
    [No Abstract]   [Full Text] [Related]  

  • 5. The histopathology of lepromatous leprosy in the nose.
    McDougall AC; Rees RJ; Weddell AG; Kanan MW
    J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much non-infectious are the "non-infectious" lepromatous leprosy patients?
    Prabhakar MC; Appa Rao AV; Krishna DR; Ramanakar TV
    Lepr India; 1983 Jul; 55(3):576-83. PubMed ID: 6361383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 9. The continuous bacteremia of lepromatous leprosy.
    Drutz DJ; Chen TS; Lu WH
    N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: recommending drug regimens to smear negative MB cases after prolonged dapsone monotherapy.
    Noordeen SK
    Lepr Rev; 1991 Sep; 62(3):340. PubMed ID: 1795596
    [No Abstract]   [Full Text] [Related]  

  • 13. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary dapsone-resistant leprosy in Shanghai Municipality.
    Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
    Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
    [No Abstract]   [Full Text] [Related]  

  • 18. Do leprosy patients in Papua New Guinea take their dapsone?
    Ree GH; Taylor VE
    P N G Med J; 1979; 22(2):145-7. PubMed ID: 399578
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 20. The nose in lepromatous leprosy; bacteriological and histopathological studies of patients treated with dapsone monotherapy for varying periods of time.
    Barton RP; Rees RJ; McDougall AC; Ellard GA
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):58-67. PubMed ID: 7200473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.